Quantrx Biomedical (OTCMKTS:QTXB) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.

Volatility & Risk

Quantrx Biomedical has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and price targets for Quantrx Biomedical and Alphatec, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quantrx Biomedical 0 0 0 0 N/A
Alphatec 0 0 1 0 3.00

Alphatec has a consensus price target of $4.00, indicating a potential upside of 48.15%. Given Alphatec’s higher probable upside, analysts plainly believe Alphatec is more favorable than Quantrx Biomedical.

Insider & Institutional Ownership

17.1% of Alphatec shares are owned by institutional investors. 21.9% of Quantrx Biomedical shares are owned by insiders. Comparatively, 44.4% of Alphatec shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Quantrx Biomedical and Alphatec’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Quantrx Biomedical N/A N/A $860,000.00 N/A N/A
Alphatec $91.69 million 1.38 -$28.98 million ($0.58) -4.66

Quantrx Biomedical has higher earnings, but lower revenue than Alphatec.

Profitability

This table compares Quantrx Biomedical and Alphatec’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Quantrx Biomedical N/A -88.93% 71.39%
Alphatec -31.60% -95.01% -18.10%

Summary

Quantrx Biomedical beats Alphatec on 6 of the 11 factors compared between the two stocks.

About Quantrx Biomedical

QuantRx Biomedical Corporation engages in the development and commercialization patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market, based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infections, urinary incontinences, general catamenial uses, and other medical needs. It also provides InSync, a feminine hygienic interlabial padand; Unique miniform, which is available as a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad, for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. The company was incorporated in 1986 and is based in Tualatin, Oregon.

About Alphatec

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and fixation products, such as Arsenal Screw System and Zodiac Spinal Fixation Systems. It also provides cervical and cervico-thoracic products, including Trestle Luxe Anterior Cervical Plate System, and Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate; and interbody Systems, such as Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer. In addition, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Receive News & Ratings for Quantrx Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantrx Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.